ECM Pulse
![Hold the fat lady: Tight AIB sell-down shows chances abound for blocks amid elusive IPO pipeline](https://c-assets.papillon.io/image/fetch/s--YnOMApIW--/f_auto/https://dkf1ato8y5dsg.cloudfront.net/uploads/79/598/640x360-4-generic21.jpg)
Hold the fat lady: Tight AIB sell-down shows chances abound for blocks amid elusive IPO pipeline
-
![Bad rates: CAB Payments "disaster" erases little faith left in IPOs 30 Oct 2023](https://c-assets.papillon.io/image/fetch/s--YnOMApIW--/f_auto/https://dkf1ato8y5dsg.cloudfront.net/uploads/79/598/640x360-istock-000006678381xlarge.jpg)
Bad rates: CAB Payments "disaster" erases little faith left in IPOs 30 Oct 2023
-
![A good deal in a bad market: CVC waits on IPO decision as Mid-East tensions rise and Vix spikes](https://c-assets.papillon.io/image/fetch/s--YnOMApIW--/f_auto/https://dkf1ato8y5dsg.cloudfront.net/uploads/79/598/640x360-3-generic6.jpg)
A good deal in a bad market: CVC waits on IPO decision as Mid-East tensions rise and Vix spikes
-
![Primary pick-me-up: companies plan equity financing as maturity wall approaches](https://c-assets.papillon.io/image/fetch/s--YnOMApIW--/f_auto/https://dkf1ato8y5dsg.cloudfront.net/uploads/79/598/640x360-gettyimages-1247661708.jpg)
Primary pick-me-up: companies plan equity financing as maturity wall approaches
-
![Simply the Best: IPO investors toast to Schott Pharma and turn eyes to CVC as next “must-have”](https://c-assets.papillon.io/image/fetch/s--YnOMApIW--/f_auto/https://dkf1ato8y5dsg.cloudfront.net/uploads/79/598/640x360-gettyimages-970046672.jpg)
Simply the Best: IPO investors toast to Schott Pharma and turn eyes to CVC as next “must-have”
-
![Mixed messages: IPO markets open, but cautious, following Arm’s share price fall](https://c-assets.papillon.io/image/fetch/s--YnOMApIW--/f_auto/https://dkf1ato8y5dsg.cloudfront.net/uploads/79/598/640x360-gettyimages-869149492.jpg)
Mixed messages: IPO markets open, but cautious, following Arm’s share price fall
-
![The spoils of war: Renk IPO to test appetite for defence stocks in the shadow of Ukraine](https://c-assets.papillon.io/image/fetch/s--YnOMApIW--/f_auto/https://dkf1ato8y5dsg.cloudfront.net/uploads/79/598/640x360-6-generic37.jpg)
The spoils of war: Renk IPO to test appetite for defence stocks in the shadow of Ukraine
-
![A Schott in the Arm – First big autumn IPOs excite but could still reopen old valuation wounds](https://c-assets.papillon.io/image/fetch/s--YnOMApIW--/f_auto/https://dkf1ato8y5dsg.cloudfront.net/uploads/79/598/640x360-2-generic46.jpg)
A Schott in the Arm – First big autumn IPOs excite but could still reopen old valuation wounds
-
![Back in block: Accelerated bookbuilds to lead autumn issuance as investors seek performance differentiators](https://c-assets.papillon.io/image/fetch/s--YnOMApIW--/f_auto/https://dkf1ato8y5dsg.cloudfront.net/uploads/79/598/640x360-gettyimages-1357752804.jpg)
Back in block: Accelerated bookbuilds to lead autumn issuance as investors seek performance differentiators
-
![Not good enough: Bankers optimistic ahead of September but most IPO sellers will wait](https://c-assets.papillon.io/image/fetch/s--YnOMApIW--/f_auto/https://dkf1ato8y5dsg.cloudfront.net/uploads/79/598/640x360-gettyimages-110177880.jpg)
Not good enough: Bankers optimistic ahead of September but most IPO sellers will wait
-
No more items to load
Load moreSomething went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports